Cerenome (PSTV) Other financing activities (2011 - 2025)
Plus Therapeutics (PSTV) posted quarterly Other financing activities of $1.4 million for Q3 2025, up 55.1% quarter-over-quarter from $882000.0 in Q1 2025.
Cerenome (PSTV) Other financing activities (2011 - 2025) Analysis & Trends
Plus Therapeutics (PSTV) has reported Other financing activities for 6 consecutive years, with $1.4 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Other financing activities changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $2.2 million (changed N/A YoY), while the FY2025 annual figure was $2.2 million, changed N/A from the prior year.
- Other financing activities advanced to $1.4 million in Q3 2025 per PSTV's latest filing, from $882000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.4 million in Q3 2025 and bottomed at $882000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 882,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Dec 31, 2015 | -3.13 Mn |
| Dec 31, 2015 | -3.13 Mn |
| Sep 30, 2015 | 3.13 Mn |
| Sep 30, 2015 | 3.13 Mn |
| Jun 30, 2015 | 1.85 Mn |
| Jun 30, 2015 | 1.85 Mn |
| Dec 31, 2014 | 85,000.00 |
| Dec 31, 2014 | 85,000.00 |
| Sep 30, 2014 | 4.07 Mn |
| Sep 30, 2014 | 4.07 Mn |
| Jun 30, 2014 | -33,000.00 |
| Jun 30, 2014 | -33,000.00 |
| Mar 31, 2014 | 33,000.00 |
| Mar 31, 2014 | 33,000.00 |
| Dec 31, 2013 | -1.52 Mn |
| Dec 31, 2013 | -1.52 Mn |